Verified ComparisonLast updated: 20 March 2026
Semaglutide vs AOD-9604
Semaglutide is an established GLP-1 agonist approved for weight management. AOD-9604 targets HGH-mediated fat loss.
Semaglutide
Metabolic
4.3/ 5
A−
AOD-9604
Metabolic
3.7/ 5
B
Editor's note
Semaglutide is approved; AOD-9604 is investigational.
| Criterion | Semaglutide | AOD-9604 |
|---|---|---|
| Mechanism | GLP-1 receptor agonism | HGH lipid-metabolism mimicry |
| Regulatory status | Approved (multiple countries, AU) | Investigational |
| Clinical evidence | Extensive | Limited |
| Weight loss magnitude | Substantial (15-22%) | Moderate |
| Lipid preservation | Variable | Lipid-selective |
Frequently asked questions
Semaglutide for approved/clinical contexts; AOD-9604 for investigational weight-loss research.
Want to read the full reviews?